Tirzepatide is a dual GLP-1/GIP receptor agonist peptide for controlled in-vitro studies of metabolic and cell-signalling pathways.
This research peptide is a synthetic amino acid sequence designed to act as a dual agonist at GLP-1 and GIP receptors. Its structure and receptor-binding profile make it useful for exploring energy balance, metabolic regulation, receptor signalling, and endocrine pathway interactions in vitro.
